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Nanotechnology had placed an impact in improving the antiproliferative activity of crude leaf (CL) and flower (CF) 
extracts of Hamelia patens on the liver (HEPG2) and breast (MCF7) carcinoma cell lines, after their encapsulation onto 
zeolite (ZSM-5) nanopores, which acts as a drug delivery system (DDS). The cytotoxicity of the new formulas showed 
remarkable improvement in the activities on HEPG2. CL had low activity on HEPG2, at the tested concentrations, but the 
ZSM-5 loaded one (CLZ) showed enhanced action with IC50=42 μg/mL. Also, the cytotoxicity of CF improved after Zeolite 
incorporation, where the IC50 has been changed from 48 μg/mL for CF to 25 μg/mL for CFZ. Moreover, the polar fraction of 
leaves extracted by methanol (Me.L) showed improvement on the cytotoxicity on MCF7 for zeolite loaded formula (Me.Z) 
(IC50 had changed from 65 to 44.4 μg/mL). Quantitative estimations for polyphenolic contents as well as the phenolic 
profiles for CF and CL extracts were inspected using HPLC-DAD to explore the bioactive phytochemical compounds. 
Acute toxicity test showed that LD50 was 1500 and 2333 mg/kg b.wt. for CL and CF, respectively. The cytogenetic study 
was also done to detect the chromosome aberrations in somatic and germ cells after CL and CF administration to mice. 
DPPH antioxidant capacity assay revealed that CL has high redox-active effect than CF. This study is a contribution to the 
development of a creative new DDS that help in cancer treatment. 
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Introduction 
Cancer is one of the most common destructive 
disease affecting millions of people per year. Cancer 
still represents the second cause of mortality in 
developed countries, after cardiovascular diseases, 
despite significant progress in prevention, diagnosis 
and development during the last 25 years. 
Discovering new drugs that are more active, more 
selective and less tumour multi-drug resistance is a 
challenge for the 21st century1. 
Herbal medicines have been widely used around 
the world since ancient times for curing various 
diseases. In modern times, natural products have been 
used for the prevention and treatment of cancer. 
Scientists are still attempting to discover the 
bioavailability of anti-cancerous compounds in 
unexplored plant species. 
Hamelia patens Jacq., family Rubiaceae, is an 
ornamental, large perennial evergreen shrub, 
indigenous to America and grown almost worldwide 
in warm areas2. Ethnobotanically, it was used for the 
treatment of a wide range of disorders. In Mexican 
traditional medicine, leaf decoction was used as 
antimicrobial, analgesic and anti-inflammatory3,4. 
H. patens extract proved to possess antibacterial
activity5, antioxidant activity6,7, anthelmintic, 
antimicrobial activity8 and Leishmanicidal activity9. 
Concerning the anticancer activity, Mena-Rejon et al10, 
performed an MTT assay on methanol extracts of 
leaves, stem and root bark on four cancerous cell 
lines; nasopharynx (KB), laryngeal (Hep-2), cervix 
adenocarcinoma (HeLa) and cervix squamous 
carcinoma cells (SiHa). Only root bark extract of 
H. patens exhibited cytotoxic activity on HeLa cells
where the IC50 was 13 µg/mL.
It had become obvious that major problems are 
being faced with the use of herbal extracts in the 
treatment of human diseases. Despite numerous 
natural products have shown great activities in 
preclinical in vitro cytotoxic tests, many of them are 








treatment. The reasons for that are the presences of 
many problems which face the use of natural products 
for clinical uses. Poor solubility, low stability in body 
fluids and the large molecular sizes of some active 
compounds lead to inefficient systemic delivery and 
poor bioavailability of the active agents11. Moreover, 
It will not be suitable to deliver the effective 
petroleum ether, chloroform, acetone, or methanol 
extracts as such, they need to be incorporated into the 
plain polymer to be more specifically targeted to the 
site of action, more soluble and stable in biological 
fluids and hence more bioavailable12. 
One of the solutions to overcome the drawbacks of 
the use of herbal medicines is the incorporation of 
active herbal extract into novel formulation systems. 
The need for a drug delivery system (DDS), a carrier 
for herbal remedies, either in nano-form or micro-
form, is a must. This will help in dose reduction 
instead of using bulk drugs and hence decreasing 
patient compliance and side effects. DDS helps to 
deliver the extract in smaller particle size and higher 
surface area leading to faster dissolution in blood13. 
Materials in micro and nanometer sizes are 
considered excellent carriers to incorporate active 
substances, like natural products and the final 
preparations have great advantages14. Hence, 
incorporation of natural products onto a microporous 
plain carrier, like zeolites, could improve the efficacy, 
bioavailability of them as the new extract DDS may 
solve many problems, like poor stability, solubility 
and toxicity, associated with nutraceuticals. This 
binding could also lead to sustained release of the 
chemopreventive agents and targeting the effective 
material to the desired action15. 
There are about 40 known natural zeolite minerals 
and more than 150 synthetic types. Zeolite is a 
microporous crystalline alumino-silicate that contains 
alkaline metal ions and water molecules. It is composed 
of a three-dimensional framework of SiO4 and AlO4 
tetrahedra. This structure results in an extended, uniform 
network of channels and pores on a nano- and sub-
nanometer scale of definitely regular dimensions16. 
Zeolites have become a challenging matter in 
different aspects of scientific research and are now 
widely applied in biological, agricultural, 
environmental and industrial technology17. The reason 
for that is the presence of AlO4 tetrahedra which 
makes zeolite framework is negatively charged18. 
These negative charges are balanced by an extra-
framework of alkaline ions that keeps the overall 
structure neutral. Besides, those water molecules are 
loosely bound and can be easily removed upon 
heating resulting in large accessible pore volume and 
high surface area. Zeolite possesses a well organized 
and regular system of channels and pores. Hence, they 
constitute ideal matrices for hosting micro and nano-
sized particles19. 
Zeolites and other related mesoporous silicates 
have comprised enormous applications in the 
encapsulation of different ions and molecules into 
them to obtain a consequently delayed release20. Also, 
Zeolite has a great potential for medical use owing to 
its stability in biological environments. Numerous 
toxicological studies proved that natural zeolites are 
nontoxic and safe materials hence they can be used in 
human and veterinary medicine21. It has been 
examined as a carrier for delayed release of 
anthelmintic and antitumor drugs22. They could be 
used as antibacterial agents or as adjuvant treatment 
of cancer23,24. A pharmaceutical preparation composed 
of zinc; erythromycin and zeolite have been used in 
the treatment of acne25. 
This research study aims to improve the cytotoxic 
effect of H. patens crude flower and leaf extracts as 
well as the polar methanol fraction of leaves (Me.L) 
and the non-polar chloroform fraction of leaves 
(Chl.L) on HEPG2 and MCF7 cancerous cell lines 
before and after the incorporation to microporous-
based drug delivery system (DDS) made from ZSM-
5. Phytochemical investigation for the polyphenolic 
contents for CL and CF were done. Acute toxicity, 
cytogenetic assay as well as antioxidant activity were 
also determined. 
 
Materials and Methods 
Plant material 
Fresh aerial parts (leaves and flowers) of Hamelia 
patens Jacq. family Rubiaceae were collected from 
the garden of National Research Centre, Dokki, Giza, 
Egypt and were kindly identified by the agricultural 
engineer, Mrs Trease Labib, Consultant of plant 
taxonomy, Ministry of Agriculture and the ex-director 
of Al-Orman Botanical Garden, Giza, Egypt and 
further confirmed by Dr Mohamed El-Gebaly, Senior 
Botanist, National Research Centre, Egypt. The plant 
was dried, ground and a voucher specimen (no. 
10/2015) was kept at Pharmacognosy Department, 
National Research Centre, Cairo, Egypt. 
 
Preparation of plant extracts 
Crude extracts 
About 100 g of each of air-dried powdered leaves 
and flowers of H. patens were exhaustively extracted 




by reflux in ultrasound instrument for 30 minutes, 
amplitude %: 60, cycles: 0.8 with 70% methanol. 
Each extract dried at 40 °C under reduced pressure to 
give crude leaf (CL) and crude flower (CF) extracts. 
 
Successive extracts 
About 100 g of dried powdered H. patens leaves 
were successively extracted with chloroform then 
with methanol in ultrasound instrument in 30 minutes, 
amplitude %: 60, cycles: 0.8. Each successive extract 
was filtered; the filtrates were dried at 40 °C under 
pressure on a rotary evaporator, weighed and kept in 
vials. Those extracts represented the non-polar and 
the polar successive fractions of leaves, respectively. 
 
Quantitative determination of total phenolic content 
The total phenolic content was determined 
according to the Folin-Ciocalteu procedure26. The 
sample (100 µL) was transferred into a test tube and 
the volume adjusted to 3.5 mL with distilled water 
and oxidized with the addition of 250 µL of Folin-
Ciocalteau reagent. After 5 minutes, the mixture was 
neutralized with 1.25 mL of 20% aqueous sodium 
carbonate (Na2CO3) solution. After 40 minutes, the 
absorbance was measured at 725 nm against the 
solvent blank. The total phenolic content was 
determined using a calibration curve prepared with 
gallic acid and expressed as milligrams of gallic acid 
equivalent (mg GAE) per gram of sample. Additional 
dilution was done if the absorbance value measured 
was over the linear range of the standard curve.  
 
Quantitative determination of total flavonoid content  
Exactly 250 µL of 5% NaNO2 was mixed with  
500 µL of extract. After 6 minutes, 2.5 mL of a 10% 
AlCl3 solution was added. After 7 minutes, 1.25 mL 
of 1 M NaOH was added, and the mixture was 
centrifuged at 5000 rpm for 10 minutes. The 
absorbance of the supernatant was measured at 510 
nm against the solvent blank. The total flavonoid 
content was expressed as mg of catechin equivalent 
(CE) per g of sample27.  
 
Quantitative determination of total anthocyanin content in 
fresh flower sample 
Total anthocyanin content was determined by the 
pH differential method for the determination of total 
monomeric anthocyanins in H. patens flower28. 
Anthocyanin was extracted from fresh tissues of  
H. patens flower by maceration in MeOH: HCl (99:1, 
v/v) solution for 24 h. The extract was clarified by 
cooling centrifugation at 10,000 rpm for 10 min at  
4 °C. The obtained supernatant was used for the assay 
of anthocyanin content. Quantification of anthocyanin 
was done spectrophotometrically at 527 nm. 
Absorbance readings were converted to the total 
amount of anthocyanin as a cyanidin-3-glucoside 
equivalent using a molar extinction coefficient (ɛ) of 
2.96×104(ref. 29). Results were expressed as mg of 
cyanidin-3-O-glucoside (Cy3G) equivalent per gram 
of fresh weight. 
 
HPLC analysis of phenolic compounds 
HPLC analysis was carried out according to Kim et 
al.30, with slight modifications using HPLC (Agilent 
Technologies, 1100 series LC, USA) equipped with 
an autosampler and a diode-array detector (DAD). 
The analytical column was Agilent Eclipse XDB C18 
(150 x 4.6 mm; 5 µm) with a C18 guard column. The 
mobile phase consisted of acetonitrile (solvent A) and 
2% acetic acid in water (v/v) (solvent B). The flow 
rate was kept at 0.8 mL/min for a total run time of 70 
minutes and the gradient program was as follows: 
100% B to 85% B in 30 minutes, 85% B to 50% B in 
20 minutes, 50% B to 0% B in 5 minutes and 0% B to 
100% B in 5 minutes. There were 10 minutes of post-
run for reconditioning. The injection volume was 10 
µL and peaks were monitored simultaneously at 280, 
320, and 360 nm for the benzoic acid, cinnamic acid 
derivatives, and flavonoids, respectively. All samples 
were filtered through a 0.45 µm Acrodisc syringe 
filter (Gelman Laboratory, MI) before injection. 
Peaks were identified by congruent retention times 
and UV spectrum and compared with those of the 
standards. 
 
HPLC analysis of anthocyanin compounds in fresh flower 
sample 
The analysis was carried out on HPLC (Agilent 
Technologies, 1100 series LC, USA) equipped with 
an autosampler and a diode-array detector (DAD). 
The analytical column was an Agilent Lichrospher 
5RP select column (250 x 4 mm id, 5 µm) with a flow 
rate of 1 mL/min at room temperature. The mobile 
phase used was a binary gradient eluent (solvent A, 
0.1% trifluoroacetic acid in water; solvent B, 0.1% 
trifluoroacetic acid in acetonitrile). Acetonitrile 
(MeCN) used was of HPLC grade (Sigma/Aldrich) 
and was degassed in an ultrasonic bath before use. 
The water was distilled using a Milli-Q system 
(Millipore). Fifty milligrams of fresh flower extract 
were dissolved overnight with 5 mL of 0.1% 
trifluoroacetic acid in methanol at 4 °C in a blender. 




The sample was centrifuged at 3000 rpm for 10 min. 
The supernatant was collected and filtered through a 
Millipore membrane (0.45 μm). The filtrate was twice 
diluted with purified distilled water. One hundred 
microliters (100 μL) of the filtrate were injected by an 
Agilent 1100 series autosampler and chromatograms 
were monitored at 521 nm. The elution program was 
5-15% B (0-5 min), 15-25% B (5-15 min), 25-100% 
B (15-30 min) and 100% B (30-40 min)31. A reference 
library of compounds was performed previously with 
2 commercially available anthocyanidin standards 
(cyanidin and delphinidin). Compounds were 
identified by comparing their retention times with 
those of the used standards. 
 
Encapsulation of extracts in ZSM-5 
The encapsulation method was prepared by 
'diffusion in liquid phase'32 in the void spaces of the 
host Zeolite (ZSM-5). 500 mg of ZSM-5 was reacted 
with a solution of 500 mg of each extract (CF, CL, 
Chl.L and Me.L), with a concentration of 10 mL of 
50% MeOH/ H2O as a solvent. Mixing was carried 
out by stirring at (495 rpm) at room temperature for 
24 hours. During this time, the original white colour 
of ZSM-5 was changed to the brownish colour of the 
extract, indicating that it was effectively entrapped 
inside the host. Samples then dried in the oven at  
60 °C for 24 hours to get rid of the solvent to yield the 
new formulae; CFZ, CLZ, Chl.Z and Me.Z). 
 
Characterization 
Microstructures of the synthesized material were 
characterized using FTIR, XRD, SEM and EDX 
elemental analysis. All extracts, before and after the 
encapsulation process were characterized by the 
mineral analysis. The prepared zeolites were 
investigated by X-ray diffraction method, using 
BRUKUR D 8 ADVANE with secondary 
monochromatic beam Cu K radiation at keV = 40 and 
mA =40. Microstructures of the prepared materials 
were scanned using SEM Model Quanta 250 FEG 
(Field Emission Gun) attached with EDX Unit 
(Energy Dispersive X-ray Analyses), with 
accelerating voltage 30 K.V., magnification 14x up to 
1000000 and resolution for Gun.1n). FEI Company, 
Netherlands. 
The specific surface area, pore and particle size 
distribution of the prepared zeolites were determined 
from nitrogen adsorption-desorption isotherms were 
measured with a high-speed gas sorption analyzer 
(NOVA 2000 series, chromatic, UK) at 77 K. Before 
measurements, the samples were out-gassed at 150 ºC 
in vacuum for 6 h. The Barrett–Emmett–Teller (BET) 
method was utilized to calculate the specific surface 
areas. The total pore volume was derived from the 
adsorption branches of the isotherms using the 
Barrett–Joyner–Halanda (BJH) method. The total 
pore volume was estimated from the amount adsorbed 
at maximum relative pressure. 
Room temperature Fourier transform infrared, 
FTIR spectra of the samples in KBr pellets were 
measured using MB154S Bomem spectrometer, 
Quebec, Canada equipment, in the range 4000–500 
cm-1 by averaging 20 scans at a maximum resolution 
of 4 cm-1. 
 
In vitro cytotoxicity assay 
Investigation of the antiproliferative activity for all 
samples (CL, CLZ, CF, CFZ, Chl.L., Chl.Z, Me.L and 
Me.Z) was done using SulphoRhodamine-B (SRB) 
Cell survival assay33 at National Cancer Institute 
(NCI), Cairo, Egypt. Two cell lines were tested; 
human breast carcinoma (MCF7) and human liver 
carcinoma (HEPG2) cell lines. As breast and liver 
cancers have become one of the most common types 
of cancers in Egypt, they were chosen for the study. 
Doxorubicin (Pharmacia, Belgium) cytotoxic drug 
was used as a references drug. 
 
In vitro antioxidant activity 
Free radical scavenging capacities of CL and CF 
were determined on the stable 1,1-Diphenyl-2-picryl-
hydrazyl (DPPH) using Trolox as a standard (Vit. E 
analogue)34. The final concentration was 200 µM for 
DPPH and the final reaction volume was 3 mL. The 
absorbance was measured at 517 nm against a blank 
of pure methanol after 60 minutes of incubation in a 
dark condition. Then the absorbance was taken at 517 
nm using the spectrophotometer. The standard curve 
was prepared using Trolox. Results were expressed as 
mg Trolox equivalents (TE)/g sample. 
 
Pharmacological in vivo studies 
Experimental animals 
Albino mice weighing 20-25 g of Swiss strain 
obtained from the animal house colony of National 
Research Centre, Cairo, Egypt. They were kept under 
the same hygienic conditions and well-balanced diet 
and water. All experiments had followed ethical 
animal care and approved by The Medical Research 
Ethics Committee, National Research Centre 
(Approval no. 15/100). 





It consisted of vitamin mixture (1%), mineral 
mixture (4%), corn oil (10%), sucrose (20%), 




About 1/10 mg of LD50 of each extract was I.P. 
administered to healthy mice for 7 days in the two 
following tests. 
 
Chromosome aberrations in somatic cells 
Chromosome preparations from bone - marrow 
(somatic cells) carried out35. 100 well spread 
metaphases were analyzed per mouse. Metaphases 
with gaps, chromatid break and fragments were 
examined and recorded under 100X magnification 
with a light microscope (Olympus, Saitama, Japan). 
 
Chromosome abnormalities in germ cells 
Chromosome preparations from spermatocytes 
(germ cells) were made36. 100 well spread diakinase-
metaphase I cells was analyzed per animal for 
chromosomal aberrations. Metaphases with X-Y 
univalents and autosomal univalents were recorded. 
For statistical analysis, the difference between treated 
groups and controls were tested with the t-test. 
 
Determination of acute toxicity 
CL and CF were tested on uninfected healthy mice 
to determine the acute toxicity via calculation of the 
median lethal dose (LD50)
37. Five groups each of 6 
mice, weighing 20-25 g each, were used. Different 
doses expressed by g/kg b.wt of each extract were 
administered. The toxic symptoms and mortality rate 
in each group were recorded after 24 hours.  
LD50 of each extract was calculated according to the 
formula:  
 
LD50 = Dm – Σ (Z x d)/ n  
 
where, Dm: is the minimum dose that kills all animals 
in the group; Z: is the mean of dead animals in two 
successive groups; d: is the constant factor between 
two successive groups; n: is the number of animals of 
each group, and Σ: is the sum of (Z x d). 
 
Results 
Quantitative phytochemical investigation 
Total phenolic, total flavonoids, and total anthocyanin contents 
Quantitative estimations of the amount of total 
phenolic (TP) and total flavonoid (TF) contents in CL 
and CF extracts, besides total anthocyanin (TA) 
contents in CF fresh sample, are shown in Table 1. 
The CL extract contains TP contents more than that 
of CF extract, while the case is reversed concerning 
TF contents. TA contents were determined for the 
fresh flowers owing to their red colour and it gave 
0.391 mg/g fresh wt. calculated as cyanidine-3-O-
glucoside equivalent. 
 
Identification of compounds by HPLC-DAD 
Some phenolic acids and flavonoids, in both CL 
and CF extracts, as well as 2 anthocyanidins, in fresh 
flower sample, were identified by comparing their 
retention times (Rt) with those of pure standards. The 
results were expressed as area % of each identified 
compound from the total area. Results are presented 
in Tables 2 and 3. It was revealed that there are 16 
compounds were identified out of 25 standards 
analyzed in CL extract. Chlorogenic acid was present 
Table 1 — Total amounts of phenolic, flavonoid and anthocyanin 







CL ext. 123.518 69.022 Not detected 
CF ext. 113.455 77.667 0.391 
 
 
Table 2 — Phenolic and flavonoids compounds identified in CL 
and CF extracts and their concentrations as detected by  
HPLC-DAD against standards 
Standard compound Rt (min.) Conc. (µg/g) 
CL CF 
Pyrogallol  4.7 9.908 ND 
Gallic acid 5.7 ND 0.053 
Protocatechuic acid 9.9 1.922 0.141 
p-hydroxybenzoic acid 15.1 ND 1.097 
Gentisic acid 16.8 ND ND 
Catechin 18.6 25.603 0.248 
Chlorogenic acid 20.6 78.244 2.169 
Caffeic acid 21.4 2.707 0.127 
Syringic acid 23 1.772 ND 
Vanillic acid 24.8 0.607 0.132 
Scopolatine 30.9 ND ND 
Ferulic acid 32.4 0.414 0.056 
Sinapic acid 33.8 ND ND 
Rutin 36.2 14.480 1.030 
p-coumaric 37.2 2.413 3.916 
Naringin 37.8 3.719 0.128 
Hisperidin 38.5 5.115 0.902 
Apigenin-7-glucoside 38.8 ND ND 
Myrcetin 39.5 ND 0.714 
Rosmarinic acid 40 15.827 5.163 
Cinnamic acid 42.8 0.076 ND 
Quercetin 43.5 0.656 0.281 
Apigenin 46 ND ND 
Kaempferol 46.5 1.302 ND 
Chyrsin 52 ND ND 




in the highest amount (78.244 µg/g), followed by 
catechin (25.6 µg/g), rosmarinic acid (15.8 µg/g), 
rutin (14.48 µg/g), and pyrogallol (9.9 µg/g). Also, 
hesperidin, naringin, caffeic, p-coumaric acid, 
protocatechuic acid, syringic acid and kaempferol are 
present in a lower amount. Traces of quercetin, 
vanillic, ferulic and cinnamic acids are also detected. 
For CF extract; 15 compounds were identified out of 
25 standard compounds analyzed. Rosmarinic acid 
was present in the highest amount (5.16 µg/g), 
followed by p-coumaric acid (3.9 µg/g), chlorogenic 
acid (2.17 µg/g), p-hydroxybenzoic acid (1.097), and 
rutin (1.03 µg/g). Traces of hesperidin, myricetin, 
quercetin, catechin, protocatechuic acid, vanillic, 
naringin, caffeic, ferulic, pyrogallol are also detected. 
HPLC analysis of CF extract against the 2 available 
anthocyanidin standards revealed that it contains 
cyanidin in a higher amount than delphinidin. 
 
Extract-DDS encapsulation 
ZSM-5 was used for the preparation of a new DDS 
to host CF, CL, Chl.L and Me.L extracts of H. patens. 
It acts by trapping the extract molecules into its 
internal framework pores and channels in the liquid 
phase. The new formulations of crude flower extract-
zeolite (CFZ), crude leaf extract-zeolite (CLZ), non-
polar ―chloroform‖ fraction of leaves-zeolite (Chl.Z) 
and polar ―methanol‖ fraction of leaves-zeolite 
(Me.Z) were confirmed by some analytical data; 
XRD, SEM coupled to EDX and IR. 
 
XRD analysis 
X-Ray diffraction patterns of CF, CL, Chl.L and 
Me.L extracts before and after ZSM-5 incorporation, 
as well as ZSM-5 alone, were represented in Fig. 1a-
e. It was clear that similar XRD zeolite profiles were 
 
 
Fig. 1 — a) XRD pattern for CL and its zeolite-incorporated versions CLZ, b) XRD pattern for CF and its zeolite-incorporated versions 
CFZ, c) XRD pattern for Chl.L and its zeolite-incorporated versions Chl.Z, d) XRD pattern for Me.L and its zeolite-incorporated versions 
Me.Z, e) XRD pattern for zeolite ZSM-5. 
Table 3 — Anthocyanin compounds identified in CF extracts and 
their concentrations analyzed by HPLC-DAD against standards 
Standard compound Rt (min.) Conc. (ug/g) 
Delphindin 16.486 30.557 
Cyanidin 17.166 258.419 




detected in samples after the extract loading with no 
changes in the zeolite peaks positions. This indicates 
the successful drug backing into zeolite nanopores 
with complete stability of zeolite structure. 
 
Scanning electron microscope (SEM) and EDX 
SEM and EDX micrographs for CFZ, CLZ, Chl.Z 
and Me.Z were shown in Fig. 2a-e and Table 4.  
Fig. 2a is showing the microstructures of ZSM-5 
zeolite wherein, the characteristic cross-twinned 
crystals appeared with nearly 5-7µm in size. EDX 
microanalysis indicated a pure ZSM-5 with only 
silicon, oxygen and sodium constituents (Table 4). 
The previous chemical composition is altered after 
extract loading and the presence of Carbon  
(Fig. 2b-e), which indicated and proved the invasion 
of both extracts into zeolite channels and pores.  
In Table 4 zeolite constituents, in terms of weight 
and atomic percentages (wt% and At%), ascertained 
the previous SEM and EDX results were nearly equal 
amounts of carbon atoms (indicating the presence of 
 
 
Fig. 2 — a) SEM and EDX of ZSM-5, b) SEM and EDX of CLZ, c) SEM and EDX of CFZ, d) SEM and EDX of Chl.Z, e) SEM and 
EDX of Me.Z.  
 
Table 4 — Chemical microanalysis for zeolite ZSM-5 before and after loading with CFZ, CLZ, Chl.Z and Me.Z extracts 
Element ZSM-5 CFZ CLZ Chl.Z Me.Z 
Wt % At % Wt % At % Wt % At % Wt % At % Wt % At % 
O 38.25 52.01 43.80 43.80 32.03 37.34 40.33 39.59 42.66 43.43 
Na 0.97 0.91 0.97 0.76 0.67 0.55 - - - - 
Si 60.78 47.08 42.65 27.81 47.70 31.68 23.51 13.14 27.29 15.82 
C - - 18.12 27.63 19.60 30.44 36.16 47.27 27.29 15.82 
Total 100 100 100 100 100 100 100 100 100 100 
Wt: weight,   At: Atom 




organic material) were contained in the micro-
analysis of zeolite crystallites when immersed into 
CF, CL, Chl.L and Me.L extracts. This indicated the 
successful process of extract-loading into zeolite 
inorganic framework channels with appreciable 
amounts of nearly 20% weight and more than 27-30% 
atoms of the drug- zeolite package. 
 
IR data 
FTIR measurements for ZSM-5, CL, CF, Chl.L and 
Me.L extracts before and after ZSM-5 incorporation 
were represented in Fig. 3a-e. 
Fig. 3a shows the FT-IT spectral bands of the 
prepared ZSM-5 zeolite. In IR spectra, in the range of 
400 to 4000 cm-1, the complete set of ZSM-5 bands 
were presented; the characteristic T-O bending 
vibration of the internal SiO4 and AlO4 tetrahedra 
appeared at 454 cm-1, the external symmetrical and 
asymmetrical stretching bands related to the T-O-T 
(where T is Si or Al) were typically positioned at 793 
and 1086 cm-1, respectively. On the other hand, the 
five-membered pentasil ring structure was assigned as 
the double ring vibration at 547 cm-1 in the same 
figure38. 
The band at 1230 cm-1 is attributed to one of the 
case sensitive bands of zeolite structures and related 
to the asymmetric stretch vibration of the external 
linkage between tetrahedra39. The band at 3500 cm-1 is 
due to hydroxyl groups (Si-OH) that are usually found 
in zeolite structures, as they are known as a group of 
hydrated minerals. So, it is clear from the figures that, 
zeolite structure was preserved and has a stable 
silicate structure that capable of hosting the plant 
extract efficiently. 
 
In vitro cytotoxicity SRB assay 
Potential cytotoxic activities of H. patens CF, CL, 
Chl.L and Me.L extracts were tested using SRB assay 
before and after ZSM-5 encapsulation against MCF7 
and HEPG2 cell lines. Results of IC50 of each sample 
 
 
Fig. 3 — a) IR data for the ZSM-5, b) IR data for H patens CL before and after ZSM, c) IR data for H patens CF. before and after ZSM, 
d) IR data for H patens Chl.L before and after ZSM, e) IR data for H patens Me.L before and after ZSM. 




are shown in Table 5. Results revealed that CL and 
CF extracts exhibited a decline in the MCF7 
cancerous cells viability in a dose-dependent  
manner and hence potent cytotoxic effect. Their 
potency was enhanced after ZSM-5 incorporation  
on HEPG2. The polar fraction of leaves (Me.L) had 
moderate cytotoxic action against MCF7 but this 
activity was improved for the encapsulated formula 
(Me.Z)  
On the other hand, the non-polar fraction of leaves 
(Chl.L) showed extremely powerful cytotoxic action 
against MCF7 and HEPG2 but the new formula 
(Chl.Z) didn't enhance the activity. 
ZSM-5 alone has weak or no activity on cancer cell 
lines as it acts as a plain, neutral incorporating agent 
that only help in decreasing the particle size of the 
effective materials40. The results support that  
H. patens leaves and flowers have great potential to 
be efficient agents in treating breast and liver cancer. 
 
In vitro antioxidant activity 
The potential antioxidant activities for CL and CF 
extracts were assessed based on the free radical 
scavenging capacities of the stable DPPH 
spectrophotometrically using Trolox as a standard 
antioxidant. Results revealed that the antioxidant 
activities were 204.147 and 19.004 mg TE/g for CL 
and CF, respectively. 
 
In vivo cytogenetic assays 
Chromosomal aberrations in mice bone marrow 
cells (somatic cells) and spermatocyte cells (germ 
cells) were examined after i.p. treatment of mice with 
CL and CF for a different period time in vivo. Types 
and percentage of metaphases with chromosomal 
aberrations induced in somatic and germ cells after 
treatment with each extract are illustrated in Tables 6 
to 9. Results showed the number and percentage of  
Table 5 — IC50 of H. patens CL and CF before and after Zeolite 
encapsulation 










CL 26 66.7 >100 42 
CF 24 45 48 25.3 
Chl.L. 18 40.6 29 44.4 
Me.L 65 44.4 44 65.5 
Doxorubicin 3.8 --- 5.87 --- 
Table 6 — Chromosomal aberrations induced in mice bone marrow cells after treatment with CL 
Treatment dose 
(mg/kg b.wt) 
Time of treatment Abnormal metaphases No. of different types of aberrations 
No. Mean (%) ± SE Chromatid gap Chromatid break Fragment 
I. Negative control -- 16 3.20±0.49 9 3 4 
II. Single treatment 
250 24 h 21 4.20±0.48 7 6 8 
500 24 h 24 4.80±0.56 8 5 11 
750 24 h 23 4.60± 0.52 11 5 7 
III. Repeated treatment 
150 7 days 21 4.20±0.60 9 8 4 
The total number of examined metaphases is 500 (5 animals/ group) 
 
 
Table 7 — Chromosomal aberrations induced in mice spermatocyte cells after treatment CL 
Treatment dose 
(mg/kg b.wt) 
Time of treatment Abnormal metaphases No. of different types of aberrations 
No. Mean (%)±SE XY-uni Auto. Uni. 
I. Negative control -- 17 3.40±0.48 11 6 
II. Single treatment 
250 24 h 22 4.40±0.7 15 7 
500 24 h 24 4.80±0.58 16 8 
750 24 h 25 5±0.48 19 6 
III. Repeated treatment 
150 7 days 23 4.60±0.68 15 8 
Total number of examined metaphases is 500 (5 animals/ group) 
XY-uni: XY- univalent; Auto. Uni.: Autosomal univalent 




Table 10 — Median lethal dose (LD50) of CL 
Dose 
(mg/kg b.wt.) 
Number of dead 
mice (of 6 mice) 
Z d (Z)x(d) 
250 0 0 250 0 
500 0 0 250 0 
1000 1 0.5 500 250 
1500 2 1.5 500 750 
2000 6 4 500 2000 
Z: is the mean of dead animals in two successive groups, d: is the 
constant factor between two successive groups. 
 
the chromosomal aberrations induced in the -ve 
control group and treated animal groups with CL and 
CF, at the doses 250, 500, and 750 mg/kg b.wt. for  
24 hours and 150 and 250 mg/kg b.wt (1/10 LD50), for 
CL and CF, respectively, for one week. The 
percentage of aberrant cells in all treated groups with 
the extracts were statistically not significant in 
comparison to the -ve control groups in somatic and 
germ cells (P <0.01).  
 
Determination of acute toxicity 
The CL and CF were tested for the determination 
of the acute toxicity via calculation of the median 
lethal dose (LD50). Results are shown in Tables 10 
and 11. LD50 of CL and CF of H. patens found to be 
1500 and 2333 mg/kg b.wt., respectively. 
Table 11 — Median lethal dose (LD50) CF 
Dose  
(mg/kg b.wt.) 
Number of dead 
mice (of 6 mice) 
Z d (Z)x(d) 
500 0 0 500 0 
1000 1 0.5 500 250 
1500 1 1 500 500 
2000 2 1.5 500 750 
2500 2 2 500 1000 
3000 4 3 500 1500 
Z:  is the mean of dead animals in two successive groups; d: is the 
constant factor between two successive groups. 
 
Discussion 
The antiproliferative activity of crude leaf (CL) and 
flower (CF) extracts as well as the polar (Me.L) and 
non-polar fraction (Chl.L) of leaves of H. patens Jacq. 
on the liver (HEPG2) and breast (MCF7) carcinoma 
cell lines, using SRB assay were investigated. An 
attempt was made to develop the bioactivity of these 
extracts by their encapsulation onto zeolite (ZSM-5) 
pores, which acts as a drug delivery system (DDS) to 
bring the molecules in a smaller size. Reinvestigating 
the cytotoxic activity of the new formulas on the same 
cancerous cells showed remarkable improvement in 
the activities on HEPG2. CL had low activity on 
HEPG2, at the tested concentrations, but the ZSM-5 
loaded one (CLZ) showed enhanced action with 
Table 8 — Chromosomal aberrations induced in mice bone marrow cells after treatment with CF 
Treatment dose 
(mg/kg b.wt) 
Time of treatment Abnormal metaphases No. of different types of aberrations 
No. Mean(%) ± SE Chromatid gap Chromatid break Fragment 
I. Negative control -- 16 3.20±0.48 7 5 4 
II. Single treatment 
250 24 h 21 4.20±0.37 9 8 4 
500 24 h 21 4.20±0.58 8 7 6 
750 24 h 25 5.00±0.70 9 10 6 
III. Repeated treatment 
250 7 days 24 4.80±0.58 7 7 10 
The total number of examined metaphases is 500 (5 animals/group) 
 
 
Table 9 — Chromosomal aberrations induced in mice spermatocyte cells after treatment with CF 
Treatment dose 
(mg/kg b.wt) 
Time of treatment Abnormal metaphases No. of different types of aberrations 
No. Mean (%) ± SE XY- uni Auto. Uni. 
I. Negative control -- 12 2.40±0.50 10 2 
II. Single treatment 
250 24 h 15 3.00±0.44 11 4 
500 24 h 17 3.40±0.67 13 4 
750 24 h 21 4. 20±0.48 12 9 
III. Repeated treatment 
250 7 days 22 4.40±0.60 16 6 
The total number of examined metaphases is 500 (5 animals/ group); XY-uni: XY- univalent; Auto. Uni.: Autosomal univalent 
 




IC50=42 µg/mL. Also, the cytotoxicity of CF 
improved after Zeolite incorporation, where the IC50 
has been changed from 48 µg/mL for CF to 25 µg/mL 
for CFZ. Also, The polar fraction of leaves (Me.L) 
revealed improved activity against MCF7 after zeolite 
incorporation (Me.Z). Meanwhile, the plain non-polar 
fraction of leaves (Chl.L) showed potent cytotoxic 
action against MCF7 and HEPG2. 
Acute toxicity determination experiment showed 
that CL and CF are safe. This indicates the low 
toxicity of the plant in vivo hence its use in herbal 
medicine is most probably useful. Traditionally, its 
leaf decoctions and infusions were taken safely by 
oral routes41. The acute toxicity of ethanol extract of 
H. patens leaves has been measured and its LD50 
found to be 2964 mg/kg b.wt i.p. and more than 5000 
mg/kg b.wt for oral doses42. This is the first 
determination of acute toxicity for H. patens flowers. 
Investigating CL and CF by in vivo chromosomal 
aberrations assays either in somatic (bone marrow) and 
germ (sperm) cells in mice indicate the safety of the 
plant leaves and flower on normal cells. To the best of 
our knowledge, this is the first study to prove the safety 
of the plant in both somatic and germ cells. The 
chromosomal aberrations in vivo assays measure the 
ability of a substance to be carcinogenic and hence 
predict if the tested substance is clastogenic43. 
Chromosomal aberrations are the mutations that may 
occur in chromosomes due to the exposure of the cell 
to a carcinogenic material. These carcinogens, which 
are responsible for the induction of neoplasm in 
humans or animals, increase the incidence of tumours. 
Chromosomal aberrations are visible changes in the 
morphology and structure of chromosomes43. Different 
structural changes occur in chromosomes due to 
abnormal divisions. That results in the reunification of 
segments in combinations that differ from those in the 
original chromosomes. These changes comprise 
deletion; due to loss, duplication; due to gain, or 
translocation; due to exchange of chromosomal 
segments. Also, chromosomal inversion may occur 
through the turning of the chromosomal segment by 
180 °C and reinserted at the same position. 
Measuring the antioxidant capacity of CL and CF 
extracts by evaluating their ability to convert the violet 
colour of DPPH to the yellow coloured α,α-diphenyl-β-
picryl hydrazine which causes a decrease in the 
absorbance wavelength44. The extent of discolouration 
demonstrates the activity of the sample as a free radical 
scavenging agent. Results revealed that CL has a good 
antioxidant effect and much higher activity than CF. 
That effect is most probably due to the presence of a 
high amount of flavonoids and phenolics in the plant. 
As it is well known, plants rich in polyphenols are 
considered highly redox-active antioxidants as these 
compounds struggle against dangerous oxidative 
damage of the cell components and hence can protect 
cells from various types of cancers44. 
Khandelwal et al.8 have investigated the 
quantitative estimation of phenol contents of different 
organs of H. patens; leaves, stems and barks and it 
was found that phenolic contents were 104.6±1.12, 
50.7±1.41, and 47.2±0.89 respectively. To the best of 
our knowledge, this is the first time investigating 
flavonoid contents in CL. Also, there was no  
previous study that investigated the quantitative 
estimation of phenolics, flavonoids, or anthocyanin 
contents in CF. 
There are previous studies that have investigated 
the chemical composition H. patens leaves extracts 
especially phenolic acids and flavonoids. Narirutin 
and rosmarinic acid were isolated from the methanol 
extract of the aerial parts of the plant45. Also, two 
flavonoids were isolated from the ethyl acetate 
extract: kaempferol-3-O-rutinoside, and (-) 
epicatechine9. Caffeoylquinic acid (chlorogenic acid) 
was detected in high amount along with quercetin 3-
O-rutinoside (rutin) and Kaempferol-3-O-rutinoside 
as major compounds that were detected by 
HPLC/ESI-MS analysis of H. patens 70% ethanol 
leaves extract, obtained by 3 different methods of 
extractions; maceration, percolation and soxhlet46 
Where hydroxycinnamic acid and catechin were 
present only in the extract obtained by maceration. 
The promising cytotoxic activity of H. patens 
leaves and flowers, against liver and breast cancer 
cells, may be attributed to the presence of a high 
amount of polyphenolic compounds. Polyphenolic 
compounds have been reported to possess many 
biological activities. One of which being potent 
anticancer agents. 
Polyphenols are a bulky group of compounds 
present abundantly in plants and can stop or treat a 
wide variety of human ailment such as cancer47. 
Numerous studies have proven that the anticancer 
effect of phenolics is due to their interference with 
each of the stages of carcinogenesis; either in 
initiation, promotion or progression of the disease48. 
The most abundant compound detected in CL is 
chlorogenic acid (CQAs; caffeoylquinic acid ester). It 




is not surprised as the plant is belonging to the coffee 
family, Rubiaceae. It has many significant biological 
activities and present in many plant species. 
Gouthamchandra et al.49 have inspected chlorogenic 
acid complex (CGA7), a decaffeinated coffee bean 
extract, for their anticancer activities against different 
cell lines. The MTT assay results indicated CGA7 has 
higher activity against mouse tumour cells (EAC and 
B16F1), followed by human colon cancer cells (HCT-
116 and HCT-15), then moderate activities against 
MCF7, Hela and HEPG2 human cancer cells. Another 
study has been carried out to investigate the molecular 
mechanism of chlorogenic acid antitumor activity. It 
was revealed that up-regulation in the expression of 
GSK-3𝛽 and APC genes and a down regulation in the 
expression of 𝛽-catenin gene occurred in the mice 
group of 20 mg/kg dosage (𝑃 <0.05). Based on the 
fact that, inducing genes GSK-3𝛽 and APC and 
inhibiting gene 𝛽-catenin will promote the apoptosis 
of tumor cells50. 
The major phenolic compound detected in CF is 
rosmarinic acid. Several studies recorded the 
efficiency of rosmarinic acid in the inhibition of 
different tumour cells like liver, breast, stomach and 
colon
51
. It showed a decrease in the colony formation 
of many kinds of colon cancer cells where it decreases 
CaCo-2 cells at dose 30 µg/mL after 24 hours52, 
SW480 colon cancer cells at dose 31.25 µg/mL after 
28 hours53. It also found to enhance the cytotoxic 
effects of 5-fluorouracil (5-FU), the chemotherapeutic 
drug, on the growth of 5-FU resistant cells54. 
Catechin and its related, more complex flavanol 
compounds, are known to acquire anticarcinogenic 
effect55. Polyphenols belonging to green tea catechins 
were found to induce apoptosis which aid in the 
treatment of numerous types of cancer as human colon 
and stomach cancer cells. From a structure-activity 
relationship viewpoint, the presence of a pyrogallol-type 
structure in a molecule is a minimum requirement for 
apoptosis induction of catechin compounds56. 
Boundless research studies have proven that 
flavonoids have diverse therapeutic effects. The most 
prominent action is their anticancer properties. 
Dietary flavonoids, such as quercetin, genistein, 
apigenin, found to be able to inhibit in vitro and  
in vivo proliferation of cancerous cells48. 
Rutin, the abundant flavonol present in various plants, 
possess many pharmacological actions. It demonstrated 
anticancer effects against different cell lines. It acts on 
reduction in tumour size of HL-60 Leukemic cells57.  
It acts by arresting the cell cycle and apoptosis of 
colorectal cancer58. It also has a cytotoxic effect against 
HTC hepatic carcinoma cells59. 
Having orange-red flowers, H. patens (syn. Firebush) 
can recruit insects, butterflies and hummingbirds for 
pollination. These flowers are found to be rich in 
anthocyanin. The detected anthocyanidins; cyanidin and 
delphinidin, are recorded to demonstrate inhibitory 
effects on breast cancer cells proliferation. Generally, 
anthocyanidins found to inhibit tumours proliferation by 
blocking the activation of the mitogen-activated protein 
kinase (MAPK) pathway in TPA-induced cultured 
mouse JB6 cells60. 
 
Conclusion 
In the present research, crude extracts of H. patens 
were incorporated in a micro-porous delivery carrier; 
zeolite ZSM-5. Each extract was loaded into the 
nanopores and channels characteristic of zeolite 
species. The loading was confirmed by XRD analysis, 
EDX, SEM and IR spectra. All data proved that the 
encapsulation was successful and ZSM-5 structure 
wasn't altered. The capacity of zeolite in carrying the 
extract was about 20% of the net weight of the zeolite 
phase. the antiproliferative activity was enhanced 
after loading the plant extracts on ZSM-5 on HEPG2 
cancerous cell lines. The investigated in vivo studies 
proved that the plant is safe for therapeutic 
administration and not toxic either to the somatic or 
genetic material. Inspections of the phytochemical 
contents for these extracts were done to explore the 
bioactive compounds and some compounds were 
detected for the first time. it was revealed that they are 
rich in active antioxidant and anticancer polyphenolic 
compounds. To the best of our knowledge, this is the 
first study using Zeolite as DDS for plant extract 
incorporation and testing them as an anticancer agent. 
This study is a contribution to the development of a 
creative new DDS with active cytotoxic agents from 
natural sources that help in cancer treatment. 
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